AJAnamik Jhunjhunwala

Anamik Jhunjhunwala

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Anamik Jhunjhunwala has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Dual Nanoparticle Labeling Enables Magnet‐Assisted Delivery and Retention of Stem Cells with Longitudinal Photoacoustic Imaging

    by Anamik Jhunjhunwala, Kelsey P. Kubelick, Masako Ishikawa, Brooke Chambliss, Myeongsoo Kim, Jinhwan Kim, Stanislav Y. Emelianov

    Magnetic targeting can improve localization of transplanted cells, but most implementations utilize endpoint assessments rather than real‐time longitudinal monitoring to assist and verify in vivo cell delivery and distribution. Here we develop a dual nanoparticle labeling strategy that integrates ultrasound (US) and photoacoustic (PA) imaging with magnetic guidance to enable image‐guided magnetic localization and retention of mesenchymal stromal cells (MSCs), together with quantitative longitudinal monitoring of the associated nanoparticle‐derived photocoustic signal. Silica‐coated gold nanorods provide photoacoustic contrast, while iron oxide nanoparticles introduce magnetic responsiveness, with nanoparticles altering neither MSC viability nor functionality. Combined loading yields a modular nanoparticle‐augmented cell system that responds to external magnetic fields and can be monitored before, during, and after delivery. Using both intramuscular and intravenous delivery routes, magnetic exposure increased acute localization, and the resulting nanoparticle‐associated photoacoustic signal distribution was monitored longitudinally using three‐dimensional photoacoustic metrics that quantify total signal, spatial footprint, and hotspot dynamics. Together, the platform establishes a foundation for image‐guided cellular localization and offers principles for combining orthogonal nanomaterials within a single cell to support improved retention and quantitative in vivo monitoring across cell therapy applications.

  • Nanoengineered cytotoxic T cells for photoacoustic image-guided combinatorial cancer therapy

    by Yunyoung Lee, Ana Maria Sandoval Castellanos, Myeongsoo Kim, Anika D. Kulkarni, Jeungyoon Lee, Anamik Jhunjhunwala, Chenxiao Wang, Younan Xia, Kelsey P. Kubelick, Stanislav Y. Emelianov, et al.

    This study aims to demonstrate that surface engineering of cytotoxic T cells with drug-loaded nanoparticles enhances nanoparticle delivery to induce a more potent combinatorial chemotherapeutic and immunotherapeutic effect, as well as enabling spatial tracking through the use of non-invasive, real-time ultrasound-guided photoacoustic imaging. Ovalbumin (OVA)-targeting OT-1 T cells were functionalized with doxorubicin-loaded, mesoporous silica-coated gold nanorods. In vitro toxicity and synergistic effects were assessed using antigen-matched OVA-expressing melanoma cells, while in vivo studies evaluated therapeutic efficacy. Ultrasound-guided photoacoustic imaging was employed to confirm the targeted delivery of the nanoengineered cells. The integration of optically active, drug-loaded nanoparticles with T cells facilitates precise image-guided delivery and enhances nanoparticle accumulation within the tumor environment, thereby maximizing the combinatorial chemo-immunotherapeutic effect. The integration of optically active, drug-loaded nanoparticles with T cells facilitates precise image-guided delivery and enhances nanoparticle accumulation within the tumor environment, thereby maximizing the combinatorial chemo-immunotherapeutic effect.


  • Open Access

    Magnetically steered cell therapy for reduction of intraocular pressure as a treatment strategy for open-angle glaucoma

    by M Reza Bahranifard, Jessica Chan, A Thomas Read, Guorong Li, Lin Cheng, Babak N Safa, Seyed Mohammad Siadat, Anamik Jhunjhunwala, Hans E Grossniklaus, Stanislav Y Emelianov, et al.

    Trabecular meshwork (TM) cell therapy has been proposed as a next-generation treatment for elevated intraocular pressure (IOP) in glaucoma, the most common cause of irreversible blindness. Using a magnetic cell steering technique with excellent efficiency and tissue-specific targeting, we delivered two types of cells into a mouse model of glaucoma: either human adipose-derived mesenchymal stem cells (hAMSCs) or induced pluripotent cell derivatives (iPSC-TM cells). We observed a 4.5 [3.1, 6.0] mmHg or 27% reduction in intraocular pressure (IOP) for 9 months after a single dose of only 1500 magnetically steered hAMSCs, explained by increased outflow through the conventional pathway and associated with a higher TM cellularity. iPSC-TM cells were also effective, but less so, showing only a 1.9 [0.4, 3.3] mmHg or 13% IOP reduction and increased risk of tumorigenicity. In both cases, injected cells remained detectable in the iridocorneal angle 3 weeks post-transplantation. Based on the locations of the delivered cells, the mechanism of IOP lowering is most likely paracrine signaling. We conclude that magnetically steered hAMSC cell therapy has potential for long-term treatment of ocular hypertension in glaucoma.